|
John J Giordano | Cirriculm Vitae | Prevent Addiction Relapse | Book Publication | Publication Papers | Educational Video Gallery |
Blog Articles
Lamar Odom Finds Relief F…
Basketball Legend & TV Reality Star Lamar Odom Finds Relief From Addiction With Ibogaine
Valentine’s Day Special R…
How chronic relapsers are getting swept under the carpet and what they can do to find sustainable recovery!
The Nexus Between Food An…
Common Neurobiological Links to Food and Drug Abuse: Brain Dopamine Regulation as a Prevention Strategy for Transfer of Addictions.
Thanksgiving, Turkey, T-T…
Without question, Thanksgiving is one of my favorite days of the year. It is a uniquely American tradition where families...
Addiction Treatment That …
From all outward appearances Dr. Peter Grinspoon looks to be the epitome of success. The Harvard trained physician has an...
7 Tips For A Full Recover…
One of the first lessons I learned – and every addict is taught – in treatment is HALT, which are...
Holiday Survival Guide Wh…
Google the word, ‘stress’ and you’ll find the definition to be: “a state of mental or emotional strain or tension...
Humanity Lost
It wasn’t that long ago that I felt encouraged about the activity surrounding our drug policy. That is not to...
Hybrid Aftercare Recovery…
Stephen Loyd, like most of his college contemporaries, was struggling to keep up with his rigorous course work. He found...
New Energy For Better Rec…
Happy New Year! I hope everyone enjoyed their holidays as much as I did. The holidays are such a special...
There’s A Little Bit Of “…
Johnny Depp’s brilliant portrayal of the orange haired Mad Hatter, Tarrant Hightopp, in Alice in Wonderland earned him a Golden...
Are (MAT) Drugs Robbing P…
With all due respect to my colleagues who might feel differently, an opioid is an opioid; period. I believe the...
An Open Letter To The Pre…
An Open Letter To The President, All Politicians, DEA, FDA And All Government Officials Involved In Drug/Addiction Treatment Policy We Cannot...
Respectfully President Ob…
Respectfully President Obama, You Can Shut Down America’s Opiate/Opioid Epidemic Tomorrow – Literally! Last night I could not have been more...
JRDS Editorial Board
John J Giordano, Pioneer In Holistic Addiction Treatment, Asked To Join JRDS Editorial Board John J Giordano, DHL, MAC, a pioneer...
Dopamine – The Single Mos…
Imagine for a moment what it would be like feeling as though you can never get enough. Have you ever...
Dying To Be Thin
By: John Giordano DHL, MACFounder of the National Institute For Holistic Addiction Studies Chaplain of the North Miami Police Department Very...
Self-Esteem Effects Every…
What is it about our self-esteem that will drive some of us to the outer edges of our sanity? Throughout...
Our Addictive Society Par…
I received so much positive feed back and questions from my last article “Our Addictive Society” that I was encouraged...
Our Addictive Society
Thirty-years ago I was as blind to addiction as nearly everyone else walking down the street. It never occurred to...
Police News - The Family …
Motivation comes in many forms. For me, it was the pain of watching my son deal with addiction. He over-doesd...
Highly-Effective, Scienti…
The hell like conditions of combat has a wide range of both physical and psychological effects on even the most...
International Conference …
In March 2013 I was invited to be a keynote speaker at the 1st International Conference on Behavioral Addictions, held...
Pain and Darkness of Depr…
Michele had struggled with the pain and darkness of depression and suicidal ideation her entire life. At one time or...
Evidenced Based Scientifi…
Addiction treatment is very personal to me. Nearly thirty-years ago it was me who was having trouble getting free of...
Videos form John J Giordano
Publications - Showing 6 of 39
1
Neuro-psychopharmacogenetics and Neurological Antecedents of Post-traumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability.
Bowirrat A, Chen TJ, Blum K, Madigan M, Bailey JA, Chuan Chen AL, Downs BW, Braverman ER, Radi S, Waite RL, Kerner M, Giordano J, Morse S, Oscar-Berman M, Gold M.Curr Neuropharmacol. 2010 Dec; 8 (4):335-58.
2
Generational Association Studies of Dopaminergic Genes in Reward Deficiency Syndrome (RDS) Subjects: Selecting Appropriate Phenotypes for Reward Dependence Behaviors
Kenneth Blum Amanda LC Chen, Marlene Oscar-Berman, Thomas JH Chen, Joel Lubar, Nancy White, Judith Lubar, Abdalla Bowirrat, Eric Braverman, John Schoolfield, Roger L Waite, Bernard W Downs, Margaret Madigan, David E Comings, Caroline Davis, Mallory M Kerner, Jennifer Knopf, Tomas Palomo, John J. Giordano, Siobhan A. Morse, Frank Fornari, Debmalya Barh, John Femino and John A Bailey. Int. J. Environ. Res. Public Health 2011.
3
Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
Blum K, Chen TJ, Downs BW, Bowirrat A, Waite RL, Braverman ER, Madigan M, Oscar-Berman M, DiNubile N, Stice E, Giordano J, Morse S, Gold M.Postgrad Med. 2009 Nov;121(6):176-96. Review.
4
Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
Blum K, Chen TJ, Chen AL, Madigan M, Downs BW, Waite RL, Braverman ER, Kerner M, Bowirrat A, Giordano J, Henshaw H, Gold MS.Med Hypotheses. 2010 Mar;74(3):513-20. Epub 2009 Nov 14.
5
Genetic Addiction Risk Score (Gars) Analysis: Exploratory Development of Polymorphic risk Alleles in Polydrug addicted males.
Blum k, Giordano j, Morse S, Liu Y, Tain J, Bowirrat A, Smolen A, Waite R, Down B, Madigan M, Kerner M, Fornari F, Barverman E, Miller D, Bailey J. IIOAB Vol1 (20 1-14.)
6
Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.
Chen TJ, Blum K, Chen AL, Bowirrat A, Downs WB, Madigan MA, Waite RL, Bailey JA, Kerner M, Yeldandi S, Majmundar N, Giordano J, Morse S, Miller D, Fornari F, Braverman ER.J Psychoactive Drugs. 2011 Apr-Jun; 43(2):108-27.
